OCON Therapeutics

Our mission is to introduce an innovative,
high-quality intrauterine drug-delivery technology
to improve and impact women’s health and quality of life

OCON Healthcare

Our mission is to introduce an innovative, high-quality intrauterine drug-delivery technology to improve and impact women’s health and quality of life

Featured in

This Is What We Do

OUR PRODUCTS

IUB® BALLERINE®, a safer¹, hormone-free next generation “smart” IUD (long acting reversible contraceptive) that fits women’s anatomy.

IUB® SEAD® (Spherical Endometrial Ablation Device), is a new paradigm in the treatment of Abnormal Uterine Bleeding (AUB) & Heavy Menstrual Bleeding (HMB): a novel, once-and-done, pain-free² and safe solution.

IUB® PRIMA®, a therapeutic-delivery to target therapy areas such as endometriosis and myomas as well as heavy menstrual bleeding and other hormonal solutions delivered directly through the uterus moving away from systemic side effects.

The World Economic Forum recognizes OCON Therapeutics as Technology Pioneer 2022 for creating new technologies and innovation that are poised to have a significant impact on business and society

why ocon?

Finally, women’s health products that are designed and managed by women for women that fit women’s anatomy and needs.

OCON’s platform technology excels in simplicity, safety, cost-effectiveness, new and innovative technology.

in the media